Literature DB >> 12838005

Transoral laser microresection for cancer of the larynx involving the anterior commissure.

Bruce W Pearson1, John R Salassa.   

Abstract

OBJECTIVE: To share the authors' experience of transoral laser microresection in the treatment of squamous cell carcinoma of the anterior commissure of the larynx. STUDY
DESIGN: Retrospective review of 39 patients with squamous carcinoma involving the anterior commissure of the larynx, all managed with transoral laser microresection between September 1996 and December 2001. Twenty-three patients had pT1 or pT2 cancers. Sixteen patients had pT3 or pT4 disease, two with N2b neck metastases. Twenty patients had cancers exhibiting spread to the subglottis. Twenty-five patients had received prior treatment(s).
METHODS: Specific data points entered into a portable database were retrospectively verified against the patient's electronic medical record. Sorting and analysis were completed in a desktop spreadsheet. We evaluated tumor recurrence, cause of death, tracheostomy, hospital length of stay, and voice quality.
RESULTS: None of the 17 patients with early cancers (pT1 or pT2a) had local recurrence, and none received postoperative radiotherapy. Five of the 22 patients with intermediate or advanced disease (pT2b/pT3 or pT4 cancer) required second treatments for persistent or recurrent disease. Of these, two had small residual foci amenable to second-stage resection by laser. One patient developed a prelaryngeal soft tissue recurrence and retained his larynx after wide local excision and radiotherapy. Two patients (both previously irradiated) developed delayed recurrences requiring total laryngectomy. Four retreated patients remained alive without disease. One patient died of other causes. Voice remained no worse after transoral laser microresection in 19 patients. It was one level worse (on a scale of 0 to 5) for 16 patients. Eleven patients received temporary tracheotomies, some for airway, some for exposure. Twelve patients left the hospital on a same-day basis. The average hospital stay was 3.3 days.
CONCLUSION: Transoral laser microsurgery is one of the options to be considered for the treatment of squamous cell cancer involving the anterior commissure of the larynx.

Entities:  

Mesh:

Year:  2003        PMID: 12838005     DOI: 10.1097/00005537-200307000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  15 in total

1.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

2.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

3.  Is frozen section reliable in transoral CO(2) laser-assisted cordectomies?

Authors:  Marc Remacle; Nayla Matar; Monique Delos; Marie-Cecile Nollevaux; Jacques Jamart; Georges Lawson
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-27       Impact factor: 2.503

Review 4.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

Review 5.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

6.  The incidence of thyroid cartilage invasion through the anterior commissure in clinically early-staged laryngeal cancer.

Authors:  Murat Ulusan; Selin Unsaler; Bora Basaran; Dilek Yılmazbayhan; Ismet Aslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-17       Impact factor: 2.503

Review 7.  Minimally Invasive Procedures for Laryngeal Carcinoma: Transoral Endoscopic Laser and Transoral Robotic Surgery.

Authors:  Özgül Topal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01

8.  Oncological Outcomes Following Transoral CO2 Laser Microsurgery for T1 Glottic Cancer.

Authors:  Ankur Batra; A Goyal; M Goyal; S Goel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-14

9.  The utility of second look microlaryngoscopy after trans oral laser resection of laryngeal cancer.

Authors:  Ashok M Shenoy; V Prashanth; T Shivakumar; Purushottam Chavan; S Akshay; Rekha V Kumar; Saraswati Devi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-11

Review 10.  Swing of the pendulum: optimizing functional outcomes in larynx cancer.

Authors:  F Christopher Holsinger
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.